Volume 12, Issue 8 (8-2014)                   IJRM 2014, 12(8): 555-0 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zheng B, Xue X, Zhao Y, Chen J, Yi Xu C, Duan P. The differential expression of microRNA-143,145 in endometriosis. IJRM 2014; 12 (8) :555-0
URL: http://ijrm.ir/article-1-573-en.html
The differential expression of microRNA-143,145 in endometriosis
Bingbing Zheng1 , Xiangyang Xue2 , Yiping Zhao3 , Jing Chen4 , Chao Yi Xu5 , Ping Duan * 6
1- Department of Obstetrics, First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China
2- Department of Microbiology, Wenzhou Medical University, Zhejiang, China
3- Department of Gynecology, Zhuji People's Hospital, Zhejiang, China
4- Department of Reproductive Medicine, Second Affiliated Hospital of Wenzhou Medical University, Zhejiang, China
5- Department of Gynecology, Second Affiliated Hospital of Wenzhou Medical University, Zhejiang, China
6- Department of Obstetrics, First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China , duanping_2011@163.com
Abstract:   (2225 Views)
Background: Recent studies showed that inappropriate expression of microRNAs (miRNAs) is strongly associated with tumor-related processes in humans (2-9,11-17).
Objective: To understand the changes of miRNAs in endometriosis.
Materials and Methods: With real-time RT-PCR, we investigated the miR-143 and miR-145 expression in eutopic (EU, n=2) and ectopic endometrium (EC, n=11) (from women with endometriosis) (as well as EU+EC, n=11), along with the normal endometrium (EN, n=22) (from women without endometriosis, but with leiomyoma).
Results: We did not find that the expression of miR-143 and/or miR-145 in EN or EC changed with menstrual cycle. But our results showed the miR-143 was up-regulated in EC (p=0.000) compared to EN. The miR-143 was also up-regulated in EU, but the difference did not reach statistically significance (p=0.053). Compared to EU, the expression of miR-143 in EC was up-regulated (p=0.016). MiR-145 had the similar characteristic to miR-143. The miR-145 was up-regulated in both EU (p=0.004) and EC (p=0.000) in compared to EN group. When compared with EU, the miR-145 in EC was up-regulated (p=0.008).
Conclusion: In conclusion, the miR-143 and miR-145 may play a certain role in the development and progression of endometriosis.
Keywords: MiRNA (microRNA), MiR-143, MiR-145, Endometriosis
Full-Text [PDF 439 kb]   (591 Downloads) |   |   Full-Text (HTML)  (364 Views)  
Type of Study: Original Article |
References
1. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997; 24: 235-258. [DOI:10.1016/S0889-8545(05)70302-8]
2. Esquela-Kerscher A, Slack FJ. Oncomirs- microRNAs with a role in cancer. Nature rev Cancer 2006; 6: 259-269. [DOI:10.1038/nrc1840]
3. Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GA. Regulatory mechanisms of microRNAs involvement in cancer. Exp Opin Biol Ther 2007; 7: 1009-1019. [DOI:10.1517/14712598.7.7.1009]
4. Manikandan J, Aarthi JJ, Kumar SD, Pushparaj PN. Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2008; 2: 330-334. [DOI:10.6026/97320630002330]
5. Akao Y, Nakagawa Y, Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006; 16: 845-850. [DOI:10.3892/or.16.4.845]
6. Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007; 26: 311-320. [DOI:10.1089/dna.2006.0550]
7. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Nat Acad Sci USA 2006; 103: 2257-2261. [DOI:10.1073/pnas.0510565103]
8. Wang Y, Lee CG. MicroRNA and cancer-focus on apoptosis. J Cell Mol Med 2009; 13: 12-23. [DOI:10.1111/j.1582-4934.2008.00510.x]
9. Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, Robertson SA, et al. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009; 23: 265-275. [DOI:10.1210/me.2008-0387]
10. Filigheddu N, Gregnanin I, Porporato PE, Surico D, Perego B, Galli L, et al. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol 2010; 2010: 369549. [DOI:10.1155/2010/369549]
11. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009; 50: 490-499. [DOI:10.1002/hep.23008]
12. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-1908. [DOI:10.1001/jama.297.17.1901]
13. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007; 26: 4442-452. [DOI:10.1038/sj.onc.1210228]
14. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: e179. [DOI:10.1093/nar/gni178]
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. [DOI:10.1006/meth.2001.1262]
16. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007; 13: 797-806. [DOI:10.1093/molehr/gam063]
17. Jia SZ, Yang Y, Lang J, Sun P, Leng J. Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis. Hum Reprod 2013; 28: 322-330. [DOI:10.1093/humrep/des413]
18. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, et al. Functional microRNA involved in endometriosis. Mol Endocrinol 2011; 25: 821-832. [DOI:10.1210/me.2010-0371]
19. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007; 148: 3814-3826. [DOI:10.1210/en.2006-1692]
20. Meola J, Rosa e Silva JC, Dentillo DB, da Silva WA, Jr., Veiga-Castelli LC, Bernardes LA, et al. Differentially expressed genes in eutopic and ectopic endometrium of women with endometriosis. Fertil Steril 2010; 93: 1750-1773. [DOI:10.1016/j.fertnstert.2008.12.058]
21. Honda H, Barrueto FF, Gogusev J, Im DD, Morin PJ. Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Reprod Biol Endocrinol 2008; 6: 59. [DOI:10.1186/1477-7827-6-59]
22. Hu WP, Tay SK, Zhao Y. Endometriosis-specific genes identified by real-time reverse transcription-polymerase chain reaction expression profiling of endometriosis versus autologous uterine endometrium. J Clin Endocrinol Metab 2006; 91: 228-238. [DOI:10.1210/jc.2004-1594]
23. Eyster KM, Klinkova O, Kennedy V, Hansen KA. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 2007; 88: 1505-1533. [DOI:10.1016/j.fertnstert.2007.01.056]
24. Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC, et al. Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol 2008; 173: 700-715. [DOI:10.2353/ajpath.2008.071128]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb